Search

Your search keyword '"Caro, Gemma"' showing total 22 results
Start Over Author "Caro, Gemma" Search Limiters Full Text
22 results on '"Caro, Gemma"'

1. Guidance on mucositis assessment from the MASCC Mucositis Study Group and ISOO: an international Delphi study

Author

Laheij, Alexa, Tonkaboni, Arghavan, Scott, Jacqui, Abasaeed, Rania, Kauzman, Adel, Flato, Adriana Do Socorro Lima, Gore, Adwaita, Hardman, Anne-Marie, Horvath, Agnes, Hovan, Allan, Al-Jamaei, Aisha, koizumi, Aya, Santos-Silva, Alan, Majorana, Alessandra, Giannini, Alexandre, Teixeira, Aléxia, Shazib, Muhammad Ali, Melvin, Alison, Filho, Aluísio Miranda, Gruza, Amanda, Brown-Dahl, Amber, Harilall, Amit, El Maghrabi, Amr, Rogulj, Ana Andabak, Curvo, Ana Raphaela, Soares, Ana Laura, Stringer, Andrea, Moreira, Andréa, Kurtzweil, Andy, Salaberry, Angelyn, Blazy, Anne, Gussgard, Anne Margrete, Lynge Pedersen, Anne Marie, Freidank, Annette, Ariyawardana, Anura, Ramseier, Adrian, Arends, Jann, Blanchard, Ariel, Paz, Adriana Sesti, Thermann, Angela, Poropat, Augusto, Freites-Martinez, Azael, Al-Azri, Abdul Rahman, Herlofson, Bente Brokstad, BalajiSubramanian, Sitaraman, Ballantyne, Barbara, Bektas-Kayhan, Kivanc, Hasséus, Bengt, Kaffenberger, Benjamin, Benites, Bernar, Kwong, Bernice, Test, Beth, Chiantia, Fernando, Pettersson, Bo, Framroze, Bomi, Bonomo, Pierluigi, Brzak, Božana Lončar, Dulmage, Brittany, Buga, Sorin, Spekssnijder, Caroline, Brown, Carlton, Melo, Antonio Carlos Moura de, Ribeiro, Ana Carolina, Silva, Caroline, Fulop, Caroline, Anderson, Carryn, Flaitz, Catherine, Massoud, Cathy, Migliorati, Cesar, Gross, Callie, Gandini, Chiara, Loprinzi, Charles, de Mooij, Charlotte, Hong, Catherine, Choi, Ying Chu, Choy, Maria, Boers-Doets, Christine, Schmeel, Leonard, Nagano, Cibele, Franco, Maria Coeli, Subramaniam, Courtney, Patrick, Carolyn, Poh, Catherine, Neuenschwander, Cristina, Virgen, Cesar, Riesenbeck, Dorothea, Weaver, Dale, Goldemberg, Daniel Cohen, Sundaresan, Daniel, Nunes, Daniela, Perez, Danyel, Travassos, Daphine, Yang, David, Ribeiro, Daniela, Kolbinson, Dean, Buick, Deborah, Saunders, Deborah, De Bortolli, Juliane, Chugh, Deepika, Markstrom, Denise, Travassos, Denise, Weikel, Dianna, Galiti, Dimitra, Peiris, Dinusha, Djordjevic, Fedja, Singhai, Pankaj, Keefe, Dorothy, Peterson, Douglas, Fonseca, Douglas, Pon, Doreen, Kovalenko, Iuliia, Polonskaia, Aleksandra, Caldas, Rogério, Saganski, Kevin, Néri, Julia, Abbott, Dennis, Yergolkar, Abhijna Vithal, Del Conte, Cristina, Passos, Januaria, Uezu, Katia, Silva, Paula, Gilbert, Steven, Yeoh, Keng, Jain, Kunal, Rastogi, Madhup, Sankaran, Satheeshkumar Poolakkad, Manne, Deborah, Shatokhina, Evgeniya, Adebayo-Olojo, Esther, Somogyi-Ganss, Eszter, Ehrenpreis, Eli, Bernaola-Paredes, Wilber, Fregnani, Eduardo, Cardoso, Elaci, Bardellini, Elena, Arvanitou, Eleni, Fontes, Elisa Kauark, Bruning, Elise, Neumann, Eloise, Madureira, Elsa, Ramires, Marcia, Papadopoulou, Erofili, Munhoz, Etiene, Spijkervet, Fred, Granzotto, Fabiana, Martins, Fabiana, Alves, Fabio, Mougeot, Farah, Aielli, Federica, Pigatti, Fernanda, Fonseca, Fernanda, Samim, Firoozeh, Carvalho, Flavia, Zelaya, Florence Cuadra, Freytes, Cesar, da Silveira, Gabriela, Torino, Gabriela, Martins, Gabriela, Silva, Geisa, Caro, Gemma, Bryan, Gemma, Radford, Georgette, Al-Qadami, Ghanyah, Albini, Giorgia, Mainville, Gisele, Gkardiakos, Georgios, Potter, Gleidston, Hoeberechts, Gulbin, Howarth, Gordon, Ottaviani, Giulia, Bradley, Grace, Verma, Gunjan, Santos, Gustavo dos, Randles-Guzzardi, Margaret, Engelbrecht, Hanlie, Wardill, Hannah, Hansen, Heidi, Hasan, Iquebal, Hata, Hironobu, Ullgren, Helena, Antunes, Heliton Spindola, Laís dos Santos, Heloísa, Weld, Howard, McInnes, Helen, Jungbluth, Hans Peter, Weng, Hsiaofen, Hewson, Ian, Santos, Ingrid, Illarramendi, Jorge, Semendric, Ines, Menge, Rol, Von Bultzingslowen, Inger, Melo, Maria da Gloria de, Leong, Iona, Fonseca, Isabella, Kalif, Isadora, Carroll, James, Coller, Janet, Beck-Mannagetta, Johann, Bowen, Joanne, Meurer, Jose, McCullough, Ricky, Powers, Jennifer, Gomez, Jesus, Lenjisa, Jimma, jaya Vangara, Leko, Jasna, Fall-Dickson, Jane, Mougeot, Jean-Luc, Fox, Joan, Epstein, Joel, Robijns, Jolien, Wu, Jonn, Palma, Patricio, Amaram-Davila, Jaya, Siderov, Jim, Raber-Durlacher, Judith, Dantas, Juliana, Jasper, Juliana, Monteiro, Juliana, Bruno, Julia, julie pfeffer, Ristivojevic, Julija Jovanovic, Brito, Juliana, Kuriakose, Jyothsna, Kabasawa, Yuji, Dave, Kanan, Barczyszyn, Karin, Lima, Karol Sartori, Secombe, Kate, White, Kate, Cooper, Kate, Katsura, Kouji, Biggs, Karen, Ciarrocca, Katharine, Dennis, Kristopher, Tomizuka, Ken, Hendler, Kevin, Komo, Ikuko, Skallsjö, Kristina, Hodgins, Kristy, Rupel, Katia, Tanaka, Keiko, Kurup, Seema, Gueiros, Luiz, Agatti, Larissa, Garzona-Navas, Laura, Guerra, Letícia, Portela, Leila, Iossi, Leilani, Elting, Linda, Baad-Hansen, Lene, Reeder, Leslie, Lang, Leticia, Menezes, Liciane, Braun, Liliana, Grando, Liliane, Lim, Mathew, Fernandez, Lina, McKeage, Lucy, Campos, Luana, Simonato, Luciana, Muniz, Luciana, van Draanen, Leah, Mizutani, Mieko, Huang, Tsai-Wei, Riad, Mahfujul, Nazar, Mahnoor, Souza, Maíra, Minamisako, Mariana, Pereira, Manoela, Mantelato, Carlos, Diniz-Freitas, Márcio, Montezuma, Marco, Andrade, Marco, Santos, Marcos, Gobbo, Margherita, Fortuna, Maria Caterina, Vitor, Mariana, Marinho, Joana, Markova, Alina, Knuchel, Marlyse, Carlesimo, Marta, Neves, Marta, Mazar, Andrew, Gomez Amarilla, Maria Cristina, Chambers, Mark, Araujo, Melissa de, Melo, Alexandre, Cole, Melody, Elsayed, Mohamed, Fliedner, Monica, Hauer-Jensen, Martin, Bouchacourt, Micaela, Brennan, Michael, Thirlwell, Michael, Nakamura, Michio, Nakagaki, Midori, Rossi, Camila, Miller, Robert, Kaprilian, Mireille, Kase, Michael, Dougan, Michael, Stokman, Monique, Monsen, Ragnhild, Morgan, Alisha, Harding, Jocelyn, Taleghani, Maryam, Genot, Marie-Therese, Seshadri, Mukund, Muzyka, Brian, Batista, Nancy, Gadd, Nancy, Tanda, Naoko, Nasr, Narmin, Garcia, Natália, Lee, Nathan, Palmier, Natalia, Brito-Dellan, Norman, Corbitt, Nancy, Pieralisi, Neli, Serrano, Verônica, Iacovelli, Nicola Alessandro, Blijlevens, Nicole, Sampaio, Norma Lúcia, Karra, Nour, Venkatesh, Niveditha, Yarom, Noam, Borin, Renata Cristina, Lemenchick, Olivia, Mendes, Ondina, Nicolatou-Galitis, Ourania, Shchitka, Vasiliy, Bossi, Paolo, Reis, Paula, Santos, Paulo Sérgio, Fernandez-Ortega, Paz, Parker, Ira, García, Raquel, Fritz, Peter, Peters, Edmund, Gardner, Pamela, Girons, Pierre Saint, Tiwari, Priya, Chaturvedi, Pravin, de Moraes, Tais, Andrade, Priscila, Nair, Raj, Gibson, Rachel, Gururaj, Rachita, Abdalla-Aslan, Ragda, Thota, Raghu, Lalla, Rajesh, Mendes, Rui Amaral, Prado, Raquel Almeida, Ongole, Ravikiran, Taybos, George, Mackey, Regina, Rego, Renata, Camilotti, Renata, Ferrari, Renata, Junior, Renato, Bensadoun, Rene-Jean, Logan, Richard, Sales, Roberta, Zanicotti, Roberta, Tunes, Roberta, Mauceri, Rodolfo, Feitoza, Rosiene, Ruddy, Kathryn, Rybczyk, Cynthia, Trager, Stephanie, Mitsunaga, Sachiyo, Gunathilake, Sahani, Saini, Rajan, Salvestrini, Viola, Mukhopadhyay, Sandip, Angeloz, Sandrina, Sankar S, Pramod, Barbosa, Luciana S Barbosa, Volkova, Elena, Elad, Sharon, Cantoreggi, Sergio, Gordon, Sharon, Brown, Shelly, Janine Tam, Shu Yie, Faleiro, Sibelle, da Silva, Silmara, de Oliveira, Silvia, Jensen, Siri Beier, Skrinjar, Ivana, Beaumont, Sophie, Sperandio, Felipe, Reese, Sandra, Roser, Steven, Seo, Sachiko, van Leeuwen, Stephanie, Sonis, Stephen, Bernard, Stephen, Samuel, Stephen Rajan, Taylor, Stuart, Maitra, Suranjan, Skulski, Susanne, Carlisle, Suzanne, Avon, Sylvie Louise, Yokota, Tomoya, Yurikusa, Takashi, Polvora, Tabata Santos, Kelock, Tabitha, Fernandes, Tauana, Wain, Taylor, Brown, Timothy, Tetsuhito konishi, Ferreira, Thalyta Amanda, Kataoka, Tomoko, Kelly, Thomas, Mori, Takehiko, Higuchi, Tomoko, Saeki, Toshiaki, Tsoukalas, Nikolaos, De Vandeul, Typhaine Maupoint, Usubuchi, Masatoshi, Lacerda, Vanessa, Tilly, Vanessa, Vigarios, Emmanuelle, Villa, Alessandro, Torregrossa, Vinicius, Selvaraj, Vinodh Kumar, Sarmento, Viviane, Heng, Vivien, Gomes-Silva, Wagner, Kandwal, Abhishek, Wilberg, Petter, Miranda e Silva, Wanessa, I'zzah Wan Mohamad Zain, Wan Nor, Park, Wonse, Tissing, Wim, Soga, Yoshihiko, Van Sebille, Bella, Matsuda, Yuhei, Zadik, Yehuda, Cao, Katrina, Cheung, Yin Ting, Fregnani, Eduardo Rodrigues, Van Sebille, Ysabella, Kauark-Fontes, Elisa, McCurdy-Franks, Emma, Finkelstein, Joel, McCarvell, Victoria, Amaral Mendes, Rui, Speksnijder, Caroline Margina, and Wardill, Hannah Rose

Published
2024
Full Text
View/download PDF

2. Efficacy of the association of topical minoxidil and topical finasteride compared to their use in monotherapy in men with androgenetic alopecia: A prospective, randomized, controlled, assessor blinded, 3‐arm, pilot trial.

Author

Rossi, Alfredo and Caro, Gemma

Subjects
*MINOXIDIL, *FINASTERIDE, *BALDNESS, *APPRAISERS, *FOLLICLE-stimulating hormone
Abstract

Purpose: Topical minoxidil (MNX) 2%–5% and oral finasteride (F) 1 mg/day are the only two pharmacological treatments authorized for androgenetic alopecia (AGA). Recently, a 2.2 mg/mL topical formulation of F was developed to minimize the systemic adverse effects associated with the oral formula. MNX and F act through different mechanisms; therefore, their association could improve clinical efficacy. To evaluate the efficacy of the association of 5% MNX and 0.25% topical F compared to their use in monotherapy, a 6‐month, prospective, randomized, assessor‐blinded trial was conducted. Patients and Methods: Forty‐two males, mean age 24 ± 3 years, with AGA (I–VII of Norwood‐Hamilton Grading Scale), treatment naive or free from any therapy for at least 6 months, were enrolled and randomly assigned to three arm treatment groups (2:1:1): group A (n = 19, the subjects applied 5% MNX in the morning and F spray in the evening), group B (n = 12, the subjects applied F spray in the evening), and group C (n = 11, the subjects applied 5% MNX twice daily). The efficacy of treatments was evaluated at baseline and after 3 and 6 months using a global photography score (GPAS; from −3 to +3) and trichoscopy evaluation and assessed by an investigator unaware of treatment allocation. At baseline and after treatments, the serum levels of follicle‐stimulating hormone (FSH), luteinizing hormone (LH), dehydroepiandrosterone sulfate (DHEA‐S), and testosterone were also evaluated. Results: All treatments resulted in an increase in hair density compared to baseline. However, this improvement was significant only for group A (MNX + F), both at three (+56 density/cm2, p < 0.05) and six (+81 density/cm2, p < 0.001) months. The mean change from baseline in hair density was higher for group A compared to other groups and statistically different compared to group B (F) (p < 0.01), both after 3 and 6 months. Group A showed a global photographic assessment score (GPAS) significantly higher compared to group B (p < 0.001) and group C (p < 0.05) both at 3 and 6 months (2.0 ± 0.7 vs. 0.6 ± 0.8 and 1.3 ± 0.6; respectively). A significantly greater percentage of subjects in Group A achieved a GPAS score of ≥2 in comparison with Groups B and C both after 3 and 6 months (79% vs. 8% and 41%, respectively). No significant differences were observed in mean hair diameter and hormonal levels between the three groups. Good tolerability was observed in all treated groups. Conclusion: The association of 5% MNX lotion and 0.25% F in spray formulation in patients with AGA showed a significantly higher clinical and instrumental efficacy compared to the monotherapies, with comparable tolerability and safety profile. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

6. Frontal Fibrosing Alopecia: A New Association with Lichen Sclerosus in Men

Author

Rossi, Alfredo, Tadiotto Cicogna, Giulia, Caro, Gemma, Fortuna, Maria Caterina, Magri, Francesca, and Grassi, Sara

Subjects
Case Series
Abstract

BACKGROUND: Frontal fibrosing alopecia (FFA) is a scarring alopecia that has been reported mostly in postmenopausal women and is characterized by frontotemporal hairline. Currently, there are only a few reports about FFA in male patients. OBJECTIVE: This study sought to analyze clinical and trichoscopic features of FFA in a case series of men and to describe the main features of FFA in male patients through a review of the literature. METHODS: Male patients with clinical and trichoscopical signs of FFA, histologically confirmed, who attended to our clinic from 2014 to 2019 were included in our study. From each patient, clinical and trichoscopic data were collected. RESULTS: Eight men with an average age of 59 years were recruited. In five patients, serrated hairline recession (i.e., a “zig-zag” pattern) was present, while three presented with linear hairline recession. Also, the eyebrows (n=3 patients), sideburns (n=2 patients), and beard (n=2 patients) were involved. Surprisingly, in two patients, an association with lichen sclerosus (LS) was present. CONCLUSION: To the best of our knowledge, this is the first report of a serrated hairline recession pattern in male patients with FFA. A new association between FFA and LS in men was also found. Further studies need to establish the extent of this association and facilitate a better comprehension of the pathophysiologic mechanisms underlying these two diseases.

Published
2021

10. Efficacy of Topical Finasteride 0.5% vs 17α-Estradiol 0.05% in the Treatment of Postmenopausal Female Pattern Hair Loss: A Retrospective, Single-Blind Study of 119 Patients

Author

Rossi, Alfredo, primary, Magri, Francesca, additional, D'Arino, Andrea, additional, Pigliacelli, Flavia, additional, Muscianese, Marta, additional, Leoncini, Pierpaolo, additional, Caro, Gemma, additional, Federico, Alessandro, additional, Fortuna, Maria Caterina, additional, and Carlesimo, Marta, additional

Published
2020
Full Text
View/download PDF

12. Multi-therapies in androgenetic alopecia: review and clinical experiences

Author

Rossi, Alfredo, Anzalone, Alessia, Fortuna, MARIA CATERINA, Caro, Gemma, Garelli, Valentina, Pranteda, Giulia, and Carlesimo, Marta

Subjects
5-alpha Reductase Inhibitors, Scalp, Treatment Outcome, Finasteride, Minoxidil, Administration, Oral, Humans, Alopecia, dermatopathology, Administration, Cutaneous, alopecia, therapy-topical, Hair
Abstract

Androgenetic alopecia (AGA) is a genetically determined progressive hair-loss condition which represents the most common cause of hair loss in men. The use of the medical term androgenetic alopecia reflects current knowledge about the important role of androgens and genetic factors in its etiology. In addition to androgen-dependent changes in the hair cycle, sustained microscopic follicular inflammation contributes to its onset. Furthermore, Prostaglandins have been demonstrated to have the ability in modulating hair follicle cycle; in particular, PGD2 inhibits hair growth while PGE2/F2a promote growth. Due to the progressive nature of AGA, the treatment should be started early and continued indefinitely, since the benefit will not be maintained upon ceasing therapy. To date, only two therapeutic agents have been approved by the Food and Drug Administration and European Medicines Agency for the treatment of AGA: topical minoxidil and oral finasteride. Considering the many pathogenetic mechanisms involved in AGA, various treatment options are available: topical and systemic drugs may be used and the choice depends on various factors including grading of AGA, patients' pathological conditions, practicability, costs and risks. So, the treatment for AGA should be based on personalized therapy and targeted at the different pathophysiological aspects of AGA.

Published
2016

13. Promoción de actividad física durante los recreos escolares: trabajando con podómetros

Author

Muñoz Caro, Gemma and Beltrán Carrillo, Vicente Javier

Subjects
7 - Bellas artes::79 -Deportes [CDU], Podómetro, Escuelas, Adolescentes
Abstract

Resumen del trabajo: El trabajo consistió en medir con podómetros la actividad física realizada por un grupo de 34 adolescentes durante los recreos escolares. Mediante el uso del podómetro se pudieron observar diferencias entre género según el juego o deporte practicado, y el efecto que provocó la intervención destinada a aumentar los niveles de actividad física.

Published
2016

17. Italian guidelines in diagnosis and treatment of alopecia areata

Author

Marta Muscianese, Giuseppe Monfrecola, Alfredo De Rossi, Stefano Astorino, Valentina Garelli, Francesco Lacarrubba, Annunziata Dattola, Giuseppe Micali, Andrea D'Arino, Alessandro Federico, Simone Garcovich, Luca Stingeni, Oriana Simonetti, Federico Bardazzi, Norma Cameli, Francesca Magri, Stefano Piaserico, Marta Carlesimo, Elena Marinello, Victor Desmond Mandel, Antonella Di Cesare, Katharina Hansel, Stefano Caccavale, Roberto D'Ovidio, Emi Dika, Annamaria Offidani, Donato Di Nunno, Flavia Pigliacelli, Lucia Villa, Cosimo Misciali, Teodora R Stan, Graziana Amendolagine, Colombina Vincenzi, Viviana Lora, Niccolò Rivetti, Maria Beatrice de Felici del Giudice, Maria Caterina Fortuna, Marina Talamonti, Claudio Feliciani, Cristina Guerriero, Alessandro Borghi, Francesca Bruni, Elisabetta Fulgione, Gabriella Fabbrocini, Andrea Carugno, Maria Carmela Annunziata, Paola Monari, Francesco Tassone, Gemma Caro, Maria C Arisi, Piergiacomo Calzavara-Pinton, Matteo Megna, Annalisa Patrizi, Graziella Babino, Bianca Maria Piraccini, Stefano Calvieri, Anna Belloni Fortina, Manuela Papini, Gloria Orlando, Stefania Barruscotti, Michele Cardone, Aurora Alessandrini, Iria Neri, Rosa Coppola, Michelangelo La Placa, Marco Galluzzo, Michela Starace, A Rossi, M Muscianese, BM Piraccini, M Starace, M Carlesimo, VD Mandel, A Alessandrini, S Calvieri, G Caro, A D’arino, A Federico, F Magri, F Pigliacelli, G Amendolagine, MC Annunziata, MC Arisi, G Babino, F Bardazzi, S Barruscotti, A Belloni Fortina, A Borghi, F Bruni, S Caccavale, P Calzavara Pinton, N Cameli, A Carugno, R Coppola, A Dattola, MB De Felici Del Giudice, A Di Cesare, E Dika, R D’ovidio, G Fabbrocini, C Feliciani, E Fulgione, M Galluzzo, S Garcovich, V Garelli, C Guerriro, K Hansel, M La Placa, F Lacarrubba, V Lora, E Marinello, M Megna, G Micali, C Misciali, G Monfrecola, I Neri, A Offidani, G Orlando, M Papini, A Patrizi, S Piaserico, N Rivetti, O Simonetti, TR Stan, L Stingeni, M Talamonti, F Tassone, L Villa, C Vincenzi, MC Fortuna, Rossi, A, Muscianese, M, Piraccini, B, Starace, M, Carlesimo, M, Mandel, V, Alessandrini, A, Calvieri, S, Caro, G, D'Arino, A, Federico, A, Magri, F, Pigliacelli, F, Amendolagine, G, Annunziata, M, Arisi, M, Astorino, S, Babino, G, Bardazzi, F, Barruscotti, S, Belloni Fortina, A, Borghi, A, Bruni, F, Caccavale, S, Calzavara-Pinton, P, Cameli, N, Cardone, M, Carugno, A, Coppola, R, Dattola, A, De Felici Del Giudice, M, Di Cesare, A, Dika, E, Dinunno, D, D'Ovidio, R, Fabbrocini, G, Feliciani, C, Fulgione, E, Galluzzo, M, Garcovich, S, Garelli, V, Guerriero, C, Hansel, K, La Placa, M, Lacarrubba, F, Lora, V, Marinello, E, Megna, M, Micali, G, Misciali, C, Monari, P, Monfrecola, G, Neri, I, Offidani, A, Orlando, G, Papini, M, Patrizi, A, Piaserico, S, Rivetti, N, Simonetti, O, Stan, T, Stingeni, L, Talamonti, M, Tassone, F, Villa, L, Vincenzi, C, Fortuna, M, Rossi, Alfredo, Muscianese, Marta, Piraccini, Bianca M, Starace, Michela, Carlesimo, Marta, Mandel, Victor D, Alessandrini, Aurora, Calvieri, Stefano, Caro, Gemma, D'Arino, Andrea, Federico, Alessandro, Magri, Francesca, Pigliacelli, Flavia, Amendolagine, Graziana, Annunziata, Maria C, Arisi, Maria Chiara, Babino, Graziella, Bardazzi, Federico, Barruscotti, Sefania, Belloni Fortina, Anna, Borghi, Alessandro, Bruni, Francesca, Caccavale, Stefano, Calzavara Pinton, Piergiacomo, Cameli, Norma, Carugno, Andrea, Coppola, Rosa, Dattola, Annunziata, De Felici Del Giudice, Maria B, Di Cesare, Antonella, Dika, Emi, D'Ovidio, Roberto, Fabbrocini, Gabriella, Feliciani, Claudio, Fulgione, Elisabetta, Galluzzo, Marco, Garcovich, Simone, Garelli, Valentina, Guerriro, Cristina, Hansel, Katharina, La Placa, Michelangelo, Lacarrubba, Francesco, Lora, Viviana, Marinello, Elena, Megna, Matteo, Micali, Giuseppe, Misciali, Cosimo, Monfrecola, Giuseppe, Neri, Iria, Offidani, Annamaria, Orlando, Gloria, Papini, Manuela, Patrizi, Annalisa, Piaserico, Stefano, Rivetti, Niccolo', Simonetti, Oriana, Stan, Teodora R, Stingeni, Luca, Talamonti, Maria, Tassone, Francesco, Villa, Lucia, Vincenzi, Colombina, Fortuna, Maria C, Rossi, A., Muscianese, M., Piraccini, B. M., Starace, M., Carlesimo, M., Mandel, V. D., Alessandrini, A., Calvieri, S., Caro, G., D'Arino, A., Federico, A., Magri, F., Pigliacelli, F., Amendolagine, G., Annunziata, M. C., Arisi, M. C., Astorino, S., Babino, G., Bardazzi, F., Barruscotti, S., Belloni Fortina, A., Borghi, A., Bruni, F., Caccavale, S., Calzavara-Pinton, P., Cameli, N., Cardone, M., Carugno, A., Coppola, R., Dattola, A., De Felici Del Giudice, M. B., Di Cesare, A., Dika, E., Dinunno, D., D'Ovidio, R., Fabbrocini, G., Feliciani, C., Fulgione, E., Galluzzo, M., Garcovich, S., Garelli, V., Guerriero, C., Hansel, K., La Placa, M., Lacarrubba, F., Lora, V., Marinello, E., Megna, M., Micali, G., Misciali, C., Monari, P., Monfrecola, G., Neri, I., Offidani, A., Orlando, G., Papini, M., Patrizi, A., Piaserico, S., Rivetti, N., Simonetti, O., Stan, T. R., Stingeni, L., Talamonti, M., Tassone, F., Villa, L., Vincenzi, C., and Fortuna, M. C.

Subjects
medicine.medical_specialty, corticosteroid, Alopecia Areata, MEDLINE, Socio-culturale, Alopecia areata, Autoimmunity, Guideline, Autoimmune Diseases, Evidence-Based Medicine, Hair Follicle, Italy, Alopecia areata, Autoimmunity, Dermatology, Disease, Minoxidil, Guideline, Autoimmune Disease, Autoimmune Diseases, Food and drug administration, 030207 dermatology & venereal diseases, 03 medical and health sciences, 0302 clinical medicine, Settore MED/35, Evidence-Based Medicine, Hair Follicle, Humans, Italy, alopecia areata, autoimmunity, guideline, autoimmune diseases, evidence-based medicine, hair follicle, humans, italy, Medicine, topical immunotherapy, integumentary system, business.industry, trichoscopy, Evidence-based medicine, medicine.disease, Trichoscopy, Clinical trial, Settore MED/35 - MALATTIE CUTANEE E VENEREE, business, Human, medicine.drug
Abstract

Alopecia Areata (AA) is an organ-specific autoimmune disorder that targets anagen phase hair follicles. The course is unpredictable and current available treatments have variable efficacy. Nowadays, there is relatively little evidence on treatment of AA from well-designed clinical trials. Moreover, none of the treatments or devices commonly used to treat AA are specifically approved by the Food and Drug Administration (FDA). The Italian Study Group for Cutaneous Annexial Disease of the Italian Society of dermatology (SIDeMaST) proposes these Italian guidelines for diagnosis and treatment of Alopecia Areata deeming useful for the daily management of the disease. This article summarizes evidence-based treatment associated with expert-based recommendations.

Published
2019

18. Efficacy and tolerability of a spray product containing hydroxypropyl chitosan, climbazole and piroctone olamine, applied twice weekly for the treatment of the pitiriasis versicolor

Author

Sandra Lorenzi, Gabriella Fabbrocini, Maria Pia De Padova, Luigia Panariello, Claudio Marasca, Gemma Caro, Giuseppe Russo, Fabbrocini, Gabriella, Panariello, Luigia, DE Padova, Maria P, Lorenzi, Sandra, Caro, Gemma, Marasca, Claudio, and Russo, Giuseppe

Subjects
Male, medicine.medical_specialty, Time Factors, Pyridones, tinea versicolor, microscopy, confocal, dermoscop, Dermoscopy, Dermatology, Hydroxypropyl Chitosan, Pharmacology, Administration, Cutaneous, chemistry.chemical_compound, Young Adult, medicine, Stratum corneum, Outpatient clinic, Humans, Chitosan, Microscopy, Confocal, Piroctone olamine, business.industry, Imidazoles, medicine.disease, Tinea versicolor, Drug Combinations, Infectious Diseases, medicine.anatomical_structure, Treatment Outcome, chemistry, Tolerability, confocal, Active compound, Ethanolamines, microscopy, Female, Dermatologic Agents, Climbazole, business
Abstract

Background The aim of this study was to demonstrate the effectiveness of a product containing hydroxypropyl chitosan, climbazole and piroctone olamine, by monitoring the adherence and the penetration of the molecules in the skin. Confocal microscopy led us to show the persistence of the active compound for a long time in the stratum corneum, thanks to the presence of hydroxypropyl chitosan. This evidence suggests a new protocol of application (a biweekly application, rather than daily). Methods Thirty patients (17 males, 13 females; average age 20.8 years) were selected from 3 dermatological centers: the Dermatological Clinic of "Federico II" University of Naples; the Dermatological outpatient clinic of Bologna private hospital "Villa Nigrisoli"; the Section of Cutaneous Appendages of the European Dermatological Institute of Milan. The study protocol entailed application of a topical spray product 2 evenings a week for 2 months. Confocal microscopy, dermoscopy and photographic documentation were performed at the moment of diagnosis (T0), 12 hours after the first application (T1), after 7 days (T2), after 1 month (T3) and after 2 months (T4). Results The improvements of clinical symptoms were documented by dermoscopy and digital photos. Confocal microscopy shows the persistence of the product in the stratum corneum, at different times of observations. Conclusions A biweekly application of a product containing hydroxypropyl chitosan, climbazole and piroctone olamine shows a clinical significative improvement, evaluated through digital photographs and dermoscopic images, with complete resolution at T4 in 100% of cases.

Published
2017

19. Chemotherapy and Cutaneous Drug Reactions

Author

Luigia Panariello, Gabriella Fabbrocini, Gemma Caro, Giuseppe Monfrecola, Fabbrocini, Gabriella, Panariello, Luigia, Caro, Gemma, and Monfrecola, Giuseppe

Subjects
Chemotherapy, medicine.medical_specialty, business.industry, medicine.medical_treatment, Cancer, Chemotherapy Skin reaction Target therapy Dermocosmetological treatment Papulo-pustular rash Paronychia Oral mucositis, medicine.disease, Rash, Dermatology, Paronychia, medicine, Mucositis, Trichomegaly, Drug reaction, medicine.symptom, Adverse effect, business
Abstract

Over the last two decades, new chemotherapeutic agents have been used for the treatment of cancer with remarkable efficacy. Despite these positive effects, several dermatologic adverse events have emerged such as xerosis, alopecia, papulo-pustular rash, nail damage, trichomegaly, hand–foot syndrome, EMPACT syndrome, and oral mucositis, affecting the quality of life of these patients. The dermatologist plays a critical role in the management of these adverse effects, through pharmacological and dermocosmetological treatment, to cure them and to prevent avoiding the interruption of these therapies for skin toxicity. To better standardize these reactions and their management is an important tool for the dermatologist.

Published
2015

20. Acneiform Rash Induced by EGFR Inhibitors: Review of the Literature and New Insights

Author

Gabriella Fabbrocini, Luigia Panariello, Gemma Caro, Sara Cacciapuoti, Fabbrocini, Gabriella, Panariello, Luigia, Caro, Gemma, and Cacciapuoti, Sara

Subjects
acneiform rash, EGFR inhibitors, papulopustular rash, medicine.medical_specialty, Side effect, business.industry, Cancer, Dermatology, Review Article, medicine.disease, Rash, Surgery, Discontinuation, EGFR inhibitor, Papulopustular rash, Epidemiology, medicine, Outpatient clinic, medicine.symptom, Acneiform rash, Prospective cohort study, business
Abstract

Acneiform rash is the most common side effect of epidermal growth factor receptor (EGFR) inhibitors (EGFRis), and it occurs in 50-100% of patients. This condition can affect the quality of life of these patients and can sometimes lead to a discontinuation of the antineoplastic therapy. Several recent prospective studies have addressed and evaluated different interventions to mitigate or reduce the severity of EGFRis-associated skin rash. With this aim, we have established a dermocosmetological outpatient clinic for cancer patients at the Department of Clinical Medicine and Surgery, University of Naples Federico II in collaboration with the Department of Dermatology and Cutaneous Surgery, Miller School of Medicine, University of Miami. An interdisciplinary network of physicians can improve the quality of life of the cancer patients, focusing on such important aspects as dermocosmetological skin care, but also on the evaluation of new therapeutic and diagnostic algorithms in order to make further progress in the field of prevention. In this review, we summarize the state of the art of the epidemiology, pathogenesis, and treatment of EGFRis acneiform rash, and we describe our outpatient clinical experience.

Published
2015

21. A New Method for the Follow-Up of Patients with Alopecia Areata.

Author

Bortone G, Caro G, Ala L, Gargano L, and Rossi A

Abstract

Background: Teledermatology is the application of information and telecommunication technologies in the field of dermatology to provide remote care services based on the exchange of clinical information within a network of professionals or between professionals and patients. Tele-trichoscopy is a non-invasive, inexpensive, and easy-to-use method that applies the principle of surface microscopy at different magnifications. Alopecia areata is a non-scarring alopecia with a chronic evolution, which often needs a close follow-up. Objectives: The aim of our work was to analyze the possible benefits of telemedicine for the follow-up of patients with alopecia areata. Materials and Methods: We enrolled patients with alopecia areata, identified during the first trichological evaluation, and we divided the patients into two groups. One group was provided with the devices necessary for a telemedicine follow-up. The other group had a conventional follow-up. The total follow-up time was one year. All of the patients' photos were blindly evaluated by a team of expert dermatologists who were asked to indicate the quality of the images. The photos were also evaluated to identify disease markers. During the follow-up period, questionnaires were administered to both groups of patients to assess the quality of the visit, the level of patient satisfaction, and to identify any issues encountered by the patients. Results: There was a high degree of concordance between the images obtained by outpatient trichoscopy and those obtained by telemedicine. The satisfaction levels were the same between the patients followed via telemedicine and those seen in the outpatient clinic. Conclusions: Telemedicine applied to trichology using trichoscopy was proven to be a valid system for managing the follow-up of patients suffering from chronic recurrent scalp diseases and, above all, for maintaining continuity of care.

Published
2024
Full Text
View/download PDF

22. Frontal Fibrosing Alopecia: A New Association with Lichen Sclerosus in Men.

Author

Rossi A, Tadiotto Cicogna G, Caro G, Fortuna MC, Magri F, and Grassi S

Abstract

Background: Frontal fibrosing alopecia (FFA) is a scarring alopecia that has been reported mostly in postmenopausal women and is characterized by frontotemporal hairline. Currently, there are only a few reports about FFA in male patients., Objective: This study sought to analyze clinical and trichoscopic features of FFA in a case series of men and to describe the main features of FFA in male patients through a review of the literature., Methods: Male patients with clinical and trichoscopical signs of FFA, histologically confirmed, who attended to our clinic from 2014 to 2019 were included in our study. From each patient, clinical and trichoscopic data were collected., Results: Eight men with an average age of 59 years were recruited. In five patients, serrated hairline recession (i.e., a "zig-zag" pattern) was present, while three presented with linear hairline recession. Also, the eyebrows (n=3 patients), sideburns (n=2 patients), and beard (n=2 patients) were involved. Surprisingly, in two patients, an association with lichen sclerosus (LS) was present., Conclusion: To the best of our knowledge, this is the first report of a serrated hairline recession pattern in male patients with FFA. A new association between FFA and LS in men was also found. Further studies need to establish the extent of this association and facilitate a better comprehension of the pathophysiologic mechanisms underlying these two diseases., Competing Interests: DISCLOSURES: The authors report no conflicts of interest relevant to the content of this article., (Copyright © 2021. Matrix Medical Communications. All rights reserved.)

Published
2021

Catalog

Books, media, physical & digital resources
See catalog results